darunavir teva 600 mg
teva pharmaceutical industries ltd, israel - darunavir - film coated tablets - darunavir 600 mg - darunavir - darunavir teva co-administered with 100 mg ritonavir, and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.
kaletra
abbvie pty ltd - ritonavir; lopinavir -
tybost
gilead sciences ireland uc - cobicistat - hiv infections - antivirals for systemic use - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
darunavir 400 milligram film coated tablet
teva b.v. - film coated tablet - 400 milligram
darunavir teva 600mg film-coated tablets
teva b.v. - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir
darunavir clonmel 600 mg film-coated tablets
clonmel healthcare ltd - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir
darunavir clonmel 800 mg film-coated tablets
clonmel healthcare ltd - darunavir - film-coated tablet - 800 milligram(s) - protease inhibitors; darunavir
darunavir clonmel 400 milligram film coated tablet
clonmel healthcare ltd - darunavir - film coated tablet - 400 milligram - protease inhibitors
darunavir rowex 75 mg film-coated tablets
rowex ltd - darunavir - film-coated tablet - 75 milligram(s) - protease inhibitors; darunavir
darunavir rowex 400 mg film-coated tablets
rowex ltd - darunavir - film-coated tablet - 400 milligram(s) - protease inhibitors; darunavir